Bergami-Santos, P C; Fonseca, F P; Camargo, A A; Barbuto, José Alexandre Marzagão 
Fonte: Cancer Detection and Prevention. Nome do evento: Internaional Symposium on Predictive Oncology and Therapy. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERGAMI-SANTOS, P C et al. Polymorphism of NRAMP-1 gene in patients with superficial bladder cancer treated with BCG immunotherapy. Cancer Detection and Prevention. Geneva: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2000APA
Bergami-Santos, P. C., Fonseca, F. P., Camargo, A. A., & Barbuto, J. A. M. (2000). Polymorphism of NRAMP-1 gene in patients with superficial bladder cancer treated with BCG immunotherapy. Cancer Detection and Prevention. Geneva: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Bergami-Santos PC, Fonseca FP, Camargo AA, Barbuto JAM. Polymorphism of NRAMP-1 gene in patients with superficial bladder cancer treated with BCG immunotherapy. Cancer Detection and Prevention. 2000 ;24 s-243.[citado 2024 nov. 05 ]Vancouver
Bergami-Santos PC, Fonseca FP, Camargo AA, Barbuto JAM. Polymorphism of NRAMP-1 gene in patients with superficial bladder cancer treated with BCG immunotherapy. Cancer Detection and Prevention. 2000 ;24 s-243.[citado 2024 nov. 05 ]
